Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
34.12
+0.14 (0.41%)
At close: Feb 27, 2026

SHE:300937 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
361.42386.67374.86457.82153.78114.23
Short-Term Investments
-4.120.83---
Trading Asset Securities
0.51.547--
Cash & Short-Term Investments
361.92392.29379.69464.82153.78114.23
Cash Growth
35.72%3.32%-18.32%202.27%34.62%-7.25%
Accounts Receivable
454.65250.81196.54146.2657.7559.38
Other Receivables
78.8683.9967.6215.9325.66.44
Receivables
533.51334.79264.16162.1883.3565.82
Inventory
501.68516.66561.24446.78468.23337.78
Prepaid Expenses
-----0.13
Other Current Assets
146.66142.24171.35190.01126.3391.15
Total Current Assets
1,5441,3861,3761,264831.68609.12
Property, Plant & Equipment
149.07161.35154.05164.95174.76163.22
Long-Term Investments
55.3345.1928.2522.421.5817.56
Goodwill
11.5716.5716.4716.362.523.13
Other Intangible Assets
43.1547.6446.4350.6542.0639.23
Long-Term Deferred Tax Assets
33.7525.4515.238.863.693.03
Long-Term Deferred Charges
28.9132.7543.9213.765.344.08
Other Long-Term Assets
0.21.576.2750.83105.43-
Total Assets
1,8661,7171,6871,5921,187839.38
Accounts Payable
518.31332.9359.66370.54184.1208.43
Accrued Expenses
12.6932.0731.9822.1910.987.2
Short-Term Debt
369.88372.32320.74235.84119.3640.05
Current Portion of Leases
-6.774.25.244.7-
Current Income Taxes Payable
22.946.144.997.871.193.16
Current Unearned Revenue
46.0449.8253.5778.8529.7721.02
Other Current Liabilities
51.9137.9325.9832.1827.918.3
Total Current Liabilities
1,022837.94801.12752.7378298.15
Long-Term Leases
6.119.764.692.545.75-
Long-Term Unearned Revenue
4.434.6856.326.16.43
Long-Term Deferred Tax Liabilities
11.9613.0813.3410.079.299.58
Other Long-Term Liabilities
0.840.356.88---
Total Liabilities
1,045865.81831.02771.64399.13314.15
Common Stock
95.6795.6795.6795.6795.6771.75
Additional Paid-In Capital
474474.01474.01475.62475.56231.26
Retained Earnings
261.94279.86284.55244.15202.28215.02
Comprehensive Income & Other
----1.5--
Total Common Equity
831.61849.54854.22813.94773.51518.02
Minority Interest
-10.971.161.826.0314.437.21
Shareholders' Equity
820.64850.69856.04819.98787.94525.23
Total Liabilities & Equity
1,8661,7171,6871,5921,187839.38
Total Debt
375.99388.85329.63243.62129.840.05
Net Cash (Debt)
-14.073.4450.06221.2123.9874.19
Net Cash Growth
--93.14%-77.37%822.60%-67.68%-10.80%
Net Cash Per Share
-0.150.040.522.320.261.03
Filing Date Shares Outstanding
95.6795.6795.6795.6795.6771.75
Total Common Shares Outstanding
95.6795.6795.6795.6795.6771.75
Working Capital
521.99548.04575.32511.1453.68310.98
Book Value Per Share
8.698.888.938.518.097.22
Tangible Book Value
776.89785.33791.32746.94728.93475.66
Tangible Book Value Per Share
8.128.218.277.817.626.63
Buildings
-116.61116.57118.19117.76-
Machinery
-94.0182.3181.9978.87-
Construction In Progress
-0.52.211.84--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.